Indication
Contaminant-Injected
1 clinical trial
2 products
Clinical trial
Immunogenicity of Concomitant Administration of Omicron-containing COVID-19 Vaccines With Influenza Vaccines : In-depth Immunogenicity Analysis.Status: Active (not recruiting), Estimated PCD: 2025-02-25
Product
Influenza vaccine